NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Old Version 1

changes.mady.by.user Safran, Tracy (NIH/NCI) [C]

Saved on

compared with

New Version 2

changes.mady.by.user Safran, Tracy (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...


SYSTEMS
Systems

Discussion Points:

    • Reiteration of Spring Vulnerability for all LexEVS dependent applications on Prod, Stage.
      • ON qa. 
    • CTS2 QA - server logs have too much data. 
      • Redirected all errors thrown into a controlled Spring framework
    • Lexevs system test - need ncimvn/../public to pull newer spring-boot
    • Jenkins having issues running Java8
      • Needed reconfiguration for NCI Meta, CTS2 and Report Writer
      • Still need to test other applications
      • Implication for the futureNCIt browser had issues on Monday

Decision Points:


LEXEVS UPDATES

LexEVS Sprint Status


Current Sprint - Sprint 200 201 (Nov 24 Dec 9 – Dec 8 20 2022)

16X237 Agile Development - Sprint Status#16X237AgileDevelopmentSprintStatus-Sprint199
  • Activities
    • LexEVS CTS2 Service - on QA. 
    • Report Exporter - On Dev
    • Vue3 Updates for Report Exporter 
    • Working on updating browser for Spring 5 - on dev

Metathesaurus issue

  • On QA - AppScan back. Request put in for StageProd
Future Planning

Discussion Points:

 Planning for Mayo team in the coming fiscal year:

Road Map outline

  • Java 8 implications
    • Do code inventory for other dependencies
    • Update to 11 or 17 - TTruong suggested 11.
    • Mark requested to look into this more closely


CTS2 Mapping/URI Resolver

Discussion Points:

  • On QA2 and QA1 - Appscan requested

Decision Points:

caDSR Query

Review requirements for caDSR query

  • They have been provided a flat file for NCIt
  • Still waiting on full requirements for additional terminologies

Statistics Dashboard

Discussion Points: 

  • Metrics All reports sent out for November 
  • Status report should be sent out today
  • Financial report likely Dec 8
  • last week

Decision Points:

Comparison/Mapping Tool

Discussion Points:

  • Probably not starting until a few months into 2023

Decision Points:

EVS transition to virtual machines

Discussion Points:

  • Server Migration 2021
    • Stage - goal to finish QA2 first. 
      • Instance of VM instantiated. Needs configuration
    • Meeting occurred. Server updated.
      • Term suggestion status - Chuck to check on this

Decision Points:

Report Exporter

Discussion Points:

  • Tomcat and Spring Vulnerability noted on the Report Exporter
    • Code completed. Being tested on Dev
    • Working on QA deployment
  • ATO expired earlier this year (Authorization to Operate)
  • Working on update to Vue3 (JavaScript Framework).
    • ~ 2 month - on week 7 of estimated 8 -
      • delayed due to high priority white label error work 
      • 3 different phases
        • Dependencies updated - complete
        • Squashing errors generated from update - complete?
        • Unit testing
          • bug squashing from this
    • Looking at updating beyond Java 8

Decision Points:

AWS Cloud to be in Separate Account

Discussion Points

  • No Response as of yet

Decision Points:

Team Absences


Mayo Team 

MSC

Leidos 

Systems - 


EVS SERVICE AND ARCHITECTURE GROUP UPDATES
EVS Service and Architecture Group

Discussion Points:

properties-extension - no impact, no longer used

Decision Points:


DATA UPDATES
Data

Discussion Points: 

  • 22.11d on Prod today
  • Monthly vocabs being worked on and should be deployed next weekTiming for next NCIm update. December?

Decision Points:


BROWSER UPDATES

Browser

Discussion Points: 

  • Meta request in for Stage

Decision Points: 


QA UPDATES

QA

Discussion Points:  (see chart)

  • tag for NCIm tested on QA
  • Monthly NCIt verified on S and P
  • Report Exporter being deployed on QA, still on Dev
    • CTS2 deployed for testing on QA

    Decision Points: 



    		TERMINOLOGIES LIFECYCLE REPORT

    Terminology Updates and Schedule 

    Discussion Points: 

    Decision Points: 

    Mark Benson TPM Update

    ...